Vor Biopharma Inc. VOR
Set alert
19.25 USD -0.43 -2.18%
At close
20.40 +1.15 +5.97%
Pre-market · Nov 3, 8:38 AM ET
18.84 Day range 20.00
6.50 52-week range 26.00
- YTD
- +47.17%
- 1 year
- -14.10%
- Open
- 19.71
- Prev close
- 19.68
- Mkt cap
- 1.18B
- Vol
- 624.09K
- Avg vol
- 946.76K
- EPS
- 293.84
- P/E
- 0.07
- Div yield
- 0.00%
More statistics
- Low
- 18.84
- High
- 20.00
- Forward P/E
- -5.30
- Beta
- 1.83
- Short ratio
- 5.69
- Inst. own
- 86.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 25, 2027
- 50-d avg
- 20.75
- 200-d avg
- 17.34
- 1y target
- 39.00
3M chart
Events in this range
- Aug 11, 2026Earnings: -1.16; estimate -0.69; surprise -68.12%
- Aug 12, 2026Rating: Wedbush · Neutral → Neutral
- Oct 21, 2026Rating: William Blair · — → Outperform
- Oct 30, 2026Earnings: -1.45; estimate -1.07625; surprise -34.73%
Signals (12)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 29, 2026 | 5 days ago |
| SMA: Bullish | Oct 27, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| RSI: Overbought | Aug 6, 2026 | 2 months ago |
Held by funds
78 US ETFs and mutual funds hold VOR · largest positions
Ownership
Held by insiders 9.26%
Held by institutions 86.86%
Float held by institutions 95.73%
Institutions 169
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| TCG Crossover Management, LLC | 9.59% | 5,673,078 | 109.21M | Jun 29, 2026 |
| FMR, LLC | 8.34% | 4,932,149 | 94.94M | Jun 29, 2026 |
| FCPM III Services B.V. | 6.96% | 4,117,354 | 79.26M | Jun 29, 2026 |
| Blackrock Inc. | 5.86% | 3,468,107 | 66.76M | Jun 29, 2026 |
| Venrock Adviser, LLC | 5.14% | 3,041,719 | 58.55M | Jun 29, 2026 |
| State Street Corporation | 4.42% | 2,616,336 | 50.36M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.62% | 1,550,885 | 29.85M | Jun 29, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 2.37% | 1,399,605 | 26.94M | Aug 30, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 2.15% | 1,270,144 | 24.45M | Jul 30, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.85% | 1,091,626 | 21.01M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.68% | 996,334 | 19.18M | Sep 29, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund | 1.10% | 650,678 | 12.53M | Jul 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANG ROBERT M.D. | Chief Executive Officer | Stock Award(Grant) | Feb 2, 2025 | 921,739 |
| ATTAR EYAL C | Officer | Sale | Feb 12, 2025 | 126,625 |
| CHAKRABORTY TIRTHA | Officer | Stock Award(Grant) | Feb 2, 2025 | 221,272 |
| CHOI HAN WOOK | Chief Financial Officer | Stock Award(Grant) | Feb 2, 2025 | 52,500 |
| MAHATME SANDESH | Chief Financial Officer | Stock Award(Grant) | Jul 8, 2025 | 13,882,800 |
| RA CAPITAL HEALTHCARE FUND,L.P. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Aug 23, 2026 | 0 |